Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates.

The stability of peptide DNA condensates was examined after introducing glutaraldehyde to cross-link surface amine groups. A 20 amino acid peptide (CWK(18)) was used to condense DNA into small (70 nm) condensates. The reaction between glutaraldehyde and peptide DNA condensates was indirectly monitored using a fluorescence-based assay to establish reaction completion in 4-5 h when using glutaraldehyde-to-peptide ratios of 1 to 4 mol equiv. Higher levels of glutaraldehyde cross-linking led to significant increases in particle size. The improved stability imparted by glutaraldehyde cross-linking was demonstrated by the increased resistance of DNA condensates to shear stress induced fragmentation. The cross-linked condensates were also significantly more resistant to in vitro metabolism by serum endonucleases. A decrease in the magnitude of transient gene expression was determined for cross-linked DNA condensates which also resulted in a 10-day steady-state expression when cross-linking with 4 mol equiv of glutaraldehyde. The results suggest that cross-linking DNA condensates may provide a means to alter the time course of transient gene expression by inhibiting DNA metabolism.

[1]  K. Mechtler,et al.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.

[2]  A. Jayakrishnan,et al.  Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. , 1996, Biomaterials.

[3]  G. Royer,et al.  Entrapment of bioactive compounds within native albumin beads. , 1983, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[4]  K. Kataoka,et al.  Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer. , 1998, Journal of pharmaceutical sciences.

[5]  K. Leong,et al.  DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[7]  L. Smith,et al.  A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. , 1996, Gene therapy.

[8]  J. C. Perales,et al.  Biochemical and Functional Characterization of DNA Complexes Capable of Targeting Genes to Hepatocytes via the Asialoglycoprotein Receptor* , 1997, The Journal of Biological Chemistry.

[9]  C. A. Pereira,et al.  Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials. , 1996, Journal of biomedical materials research.

[10]  A. Kabanov,et al.  DNA complexes with polycations for the delivery of genetic material into cells. , 1995, Bioconjugate chemistry.

[11]  C. Wu,et al.  Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. , 1993, The Journal of biological chemistry.

[12]  D. Scherman,et al.  Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. , 1998, Biochimica et biophysica acta.

[13]  J. Bonadio,et al.  Stability of peptide-condensed plasmid DNA formulations. , 1998, Journal of pharmaceutical sciences.

[14]  Seyhan N. Eğe,et al.  Organic Chemistry: Structure and Reactivity , 1998 .

[15]  Dexi Liu,et al.  Serum independent liposome uptake by mouse liver. , 1996, Biochimica et biophysica acta.

[16]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Mechtler,et al.  DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. , 1991, Bioconjugate chemistry.

[18]  C. Hung,et al.  Albumin microspheres. I: Physico-chemical characteristics. , 1989, Journal of microencapsulation.

[19]  M. Burton,et al.  Albumin Microspheres as Vehicles for the Sustained and Controlled Release of Doxorubicin , 1989, The Journal of pharmacy and pharmacology.

[20]  C. Wu,et al.  Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. , 1994, Nucleic acids research.

[21]  Leaf Huang,et al.  Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA , 1997, Gene Therapy.

[22]  C. Pouton,et al.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[23]  F. Szoka,et al.  Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. , 1993, Bioconjugate chemistry.

[24]  A. Ichinose,et al.  Binding of Cationic α-Helical Peptides to Plasmid DNA and Their Gene Transfer Abilities into Cells* , 1997, The Journal of Biological Chemistry.

[25]  A. Thierry,et al.  Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA , 1997, Gene Therapy.

[26]  L. Smith,et al.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. , 1998, Biophysical journal.

[27]  D. Curiel,et al.  Receptor-mediated gene delivery employing lectin-binding specificity. , 1994, Gene therapy.

[28]  K. Rice,et al.  Comparative gene transfer efficiency of low molecular weight polylysine DNA-condensing peptides. , 1999, The journal of peptide research : official journal of the American Peptide Society.